ANVISA registration 80258020133Valid until May 02, 2032SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS)
ANVISA Registration Number: 80258020133CEPALAB LABORATÓRIOS LTDAGUANGZHOU WONDFO BIOTECH CO., LTDRisk Class III
Device names
- Technical name
- SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS)
- Risk class
- Class III
PT: AUTOTESTE PARA ANTÍGENO DO SARS-COV-2 (CORONAVÍRUS)
Registration details
- Registration Number
- 80258020133
- Process Number
- 25351078939202244
- CNPJ
- 02248312000144
Company information
- Registration Holder
- CEPALAB LABORATÓRIOS LTDA
- Manufacturer
- GUANGZHOU WONDFO BIOTECH CO., LTD
- Manufacturing Country
- China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
- Publication Date
- May 02, 2022
- Validity
- 02/05/2032
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80258020133 and manufactured by GUANGZHOU WONDFO BIOTECH CO., LTD. The registration is held by CEPALAB LABORATÓRIOS LTDA with validity until May 02, 2032.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.